10450 Science Center Drive
San Diego, CA 92121
(858) 625 2424
5 Sylvan Way
Parsippany, NJ 07054
(973) 254 3560
The potential benefits of DepoFoam® have attracted partners pursuing reformulations of blockbuster product candidates. Pacira is developing new formulations of traditional small molecule and biologic therapies to build a pipeline of commercial opportunities for proprietary pursuit, as well as for out-licensing. For partners, this approach provides a low risk clinical and regulatory development opportunity.
- Pacira has created formulations for six of the current top selling biologics; including EPO, G-CSF, hGH, INF-α, FSH, and one undisclosed molecule.
- Pacira has also developed feasibility data on a number of products. Among these is a project to reengineer the delivery of a disease-modifying antirheumatic drug to extend its delivery over several days while minimizing side effects.
- Pacira will consider partnering opportunities in human and animal healthcare where Exparel™ has the potential to change pain management treatment paradigms.
Pacira owns and operates cGMP clinical and commercial manufacturing facilities in San Diego that are fully compliant with all major regulatory authorities. We have the capability to manufacture DepoFoam-based medications for our acute care customers, our partners, and our pipeline products.
To inquire how Pacira’s DepoFoam® technology may enhance your product needs or products that are available for out-licensing, please contact our Business Development team at busdev@pacira.com.
2b that provides Sustained Plasma IFN-- Current strategic and supply partnerships
- EKR Therapeutics, Inc.
- Enzon Pharmaceuticals Inc.
- Flynn Pharma Ltd.
- Mundipharma International Holdings Ltd.
- Ongoing development collaborations
- Maruho Co. Ltd.
- Amylin Phamaceuticals
- Other undisclosed partners